EFPIA：2026年欧洲制药行业关键数据报告（英文版）

The industry has already played a key role in improving patient outcomes and quality of life. Today, people in Europe can expect to live up to 30 years longer than a century ago. This progress reflects major breakthroughs and many incremental advances in biopharmaceutical research, contributing to significant reductions in mortality, including from HIV/AIDS and several cancers. Many conditions once considered life-threatening can now be managed. High blood pressure and cardiovascular diseases